Xiamen Amoytop Biotech Co Ltd Capital Reinvestment Ratio
Xiamen Amoytop Biotech Co Ltd capital reinvestment ratio. Xiamen Amoytop Biotech Co Ltd (688278) has a Capital Reinvestment Ratio of 0.13x as of September 2023, meaning it reinvests 0% of its operating cash flow (CN¥332.29 Million) in capital expenditures (CN¥43.00 Million). Check Xiamen Amoytop Biotech Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Xiamen Amoytop Biotech Co Ltd (2016–2024)
Capital reinvestment ratio of Xiamen Amoytop Biotech Co Ltd from 2016 to 2024. This chart tracks Xiamen Amoytop Biotech Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore 688278 net asset momentum to track the company's year-over-year net asset growth rate.
Xiamen Amoytop Biotech Co Ltd Capital Reinvestment Ratio by Year (2016–2024)
Xiamen Amoytop Biotech Co Ltd capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Xiamen Amoytop Biotech Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | CN¥430.63 Million | CN¥251.35 Million | ▲ +22.3% |
| 2023 | 0.48x | CN¥512.10 Million | CN¥244.48 Million | ▼ -20.9% |
| 2022 | 0.60x | CN¥363.16 Million | CN¥219.17 Million | ▼ -25.8% |
| 2021 | 0.81x | CN¥234.78 Million | CN¥190.93 Million | ▼ -36.6% |
| 2020 | 1.28x | CN¥92.61 Million | CN¥118.81 Million | ▲ +252.9% |
| 2019 | 0.36x | CN¥123.30 Million | CN¥44.83 Million | ▲ +122.0% |
| 2018 | 0.16x | CN¥89.15 Million | CN¥14.60 Million | ▼ -92.0% |
| 2016 | 2.05x | CN¥42.43 Million | CN¥87.03 Million | — |